Perimeter Medical Imaging AI to Present at the 13th Annual LD Micro Main Event Investor Conference
TORONTO, ON / ACCESSWIRE / December 11, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven...
Day: December 11, 2020
CordovaCann Continues Retail Expansion and Opens Fourth Star Buds Cannabis Store in Ontario
TORONTO, ON / ACCESSWIRE / December 11, 2020 / CordovaCann Corp. (CSE:CDVA)(OTCQB:LVRLF) ("Cordova" or the "Company"), a cannabis-focused consumer products...
9 Meters Biopharma, Inc. Prices Public Offering of Common Stock
RALEIGH, NC / ACCESSWIRE / December 11, 2020 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-stage rare and...
Avinger Adjourns Annual Meeting of Stockholders
Scheduled to Reconvene December 23, 2020 Avinger Strongly Encourages Stockholders to Immediately Vote FOR Proposal 3 REDWOOD CITY, CA /...
Purek Holdings Corp. Announces Commencement of Trading on the TSX Venture Exchange
PHOENIX, Dec. 11, 2020 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company") (TSX Venture: PKAN), formerly AF1 Capital Corp., is...
Cerner Announces Increased Quarterly Dividend
Company to Award $0.22 Per Issued and Outstanding Share to Stockholders; an Increase of 22%KANSAS CITY, Mo., Dec. 11, 2020...
Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference
LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company...
Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
New data accrued from 19 PNH patients treated for over 30 cumulative patient-years show that self-administered nomacopan is well-tolerated and...
Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress
Pivotal Phase III study in patients with severe dermatological condition bullous pemphigoid (BP) planned to start H1 2021 following successful...
SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast
– Immune Stimulation Augmented by +1,300% at 6-months Post-NPS Treatment – – Statistically Significant Difference of Duration of Immune Response...
Assure Holdings Announces Results of Annual General and Special Meeting of Shareholders
DENVER, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
Soleno intends to submit plans to FDA to conduct further analyses of clinical data from completed and ongoing studies of...
CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes
CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes CHMP issues positive opinion for...
New sales reporting structure introduced. 2020 organic sales growth outlook now expected at 0%, from previously -2% to +2%
Please read the full announcement in PDF Attachment 2020_64_New_segment_reporting
Galecto Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
Successfully completed listing on US Nasdaq and raised over $150 million during recent IPO and preceding crossover round Funds to...
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies...
Lexicon Announces Offering of Common Stock
THE WOODLANDS, Texas, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it had entered...
Financial calendar for Zealand Pharma in 2021
Company announcement – No. 59 / 2020 Copenhagen, December 11, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20...
Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020
NORCROSS, Ga., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins,...
BioSyent Announces Renewal of Normal Course Issuer Bid
MISSISSAUGA, Ontario, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce...